BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 136 filers reported holding BIOLIFE SOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,714,887 | -45.2% | 558,606 | -12.3% | 0.00% | -25.0% |
Q2 2023 | $14,070,002 | +32.5% | 636,602 | +30.4% | 0.00% | 0.0% |
Q1 2023 | $10,618,516 | +214849.7% | 488,275 | +79.9% | 0.00% | +300.0% |
Q4 2022 | $4,940 | -99.6% | 271,419 | +352.8% | 0.00% | 0.0% |
Q3 2022 | $1,363,000 | +640.8% | 59,937 | +348.8% | 0.00% | – |
Q2 2022 | $184,000 | -83.8% | 13,356 | -73.3% | 0.00% | – |
Q1 2022 | $1,138,000 | -67.1% | 50,076 | -46.0% | 0.00% | -100.0% |
Q4 2021 | $3,454,000 | -50.1% | 92,667 | -43.4% | 0.00% | -50.0% |
Q3 2021 | $6,928,000 | +102.1% | 163,713 | +112.5% | 0.00% | +100.0% |
Q2 2021 | $3,428,000 | +24.7% | 77,039 | +1.3% | 0.00% | 0.0% |
Q1 2021 | $2,750,000 | -12.4% | 76,042 | -3.3% | 0.00% | 0.0% |
Q4 2020 | $3,138,000 | +36.9% | 78,639 | -0.8% | 0.00% | 0.0% |
Q3 2020 | $2,293,000 | +105.1% | 79,237 | +15.7% | 0.00% | – |
Q2 2020 | $1,118,000 | +208.0% | 68,469 | +79.1% | 0.00% | – |
Q1 2020 | $363,000 | – | 38,239 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 7,721,535 | $170,645,924 | 14.91% |
Gagnon Advisors, LLC | 360,758 | $7,972,751 | 5.34% |
Park West Asset Management LLC | 2,081,083 | $45,991,934 | 4.02% |
Meros Investment Management, LP | 324,479 | $7,170,986 | 3.56% |
GAGNON SECURITIES LLC | 637,576 | $14,090,429 | 2.93% |
Mesirow Financial Investment Management, Inc. | 16,947 | $374,529 | 1.59% |
Zweig-DiMenna Associates LLC | 256,000 | $5,657,600 | 0.71% |
GENEVA CAPITAL MANAGEMENT LLC | 1,561,443 | $34,507,882 | 0.68% |
PALISADE CAPITAL MANAGEMENT, LP | 1,134,352 | $25,069,179 | 0.67% |
Penbrook Management LLC | 41,500 | $917,150 | 0.66% |